
Evelyn Beas
@evelynbeas2
oncologist @incmnszmx
ID: 1544045488542040064
04-07-2022 19:48:54
22 Tweet
77 Followers
123 Following


Excited to say I'm #hereforDDW presenting our work on jugular #POCUS as a predictor of a high CVP in patients with cirrhosis, also recently accepted at AJG - The American Journal of Gastroenterology 🧵



Important first step for #pocus in #cirrhosis Mario AJ Leal-Villarreal on the accuracy of left internal jugular US for detecting increased pressure. It is high. Now, let’s see how these measures guide treatment, fluids vs pressors etc doi.org/10.14309/ajg.0… #livertwitter


The therapeutic landacape of #bladdercancer has changed!! ✅ Patients w FGFR alterations can be treated w erdafitinib 👩🏻🔬🏨🧬 🔹Phosphorus needed for dose titration 🫙 🔹Skin, nails & 👁️ toxicity!!! 🔹High disease control rate Evelyn Beas Yuly A. Remolina Francisco Castro Thomas Flaig


Honored to share our review on #livertransplant in Latin America, recently published in The Lancet Reg Health-Americas ! authors.elsevier.com/sd/article/S26… Forever grateful to everyone involved!



🚨PAPER ALERT‼️ So happy to see my PhD work finally out in JCI insight Some #flozination of our own in Norma Bobadilla Lab 🇲🇽 👇🏿 df6sxcketz7bb.cloudfront.net/manuscripts/17… I’ll walk y’all briefly through this 🥰



Today I presented some of the hard work of the urologic oncology clinic INCMNSZ_Uronco at ASCO! Proud to be part of this team!


We came up with this review after facing the treatment challenges for a WLWH and cervical cancer. We hope it is useful for other cancer care providers. Thanks to our amazing team Alejandra Martinez-Cannon Sergio Contreras Andrea Mac Donald Salvador Jaime-Casas, MD , Javier and Citlali

Congrats to our fellows for this paper! Evelyn Beas @HeRagosan José Luis Rodríguez 🔵Overview of hereditary cancer syndromes associated w RCC 🟡Recommendations for genetic testing 🟢Tuberous sclerosis complex symptoms and mTOR inhibitors efficacy & safety pubmed.ncbi.nlm.nih.gov/39475505/



Inicia sesion de #GU25 #prostatecancer 🔴 PORTOS: Firma genética predictora respuesta a dosis RT 🟠 Comparación emulada aleatorizada PR vs RT en CaPr de alto riesgo 🔵 TALAPRO-2: SG final pobalción no seleccionada Neeraj Agarwal, MD, FASCO 🟢 STOPCAP matanálisis benevicio de ARSI en mCPHS


Muy felices de la graduación PAEM UNAM INCMNSZ de Uro-Oncología INCMNSZ_Uronco 🥳👩🏻🎓👨🏻🎓👩🏻⚕️👨🏻⚕️🦀🥂 Felicidades Generación 2024-2025 Evelyn Beas Roberto Carlos Rojas Moreno muy orgullosos 🍻 Gracias a quienes hacen esto posible Yuly A. Remolina Ana Lilia Mtz.

